LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 5 of 15: Mean cell count and mean growth rate across biological replicate 2. - Dataset (ID:20241)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Relative Growth Rate After Treatment |
---|---|---|---|---|---|---|---|---|---|---|---|
MDA-MB-231 | PD0325901 | 0.12 | uM | LJP5 | 72 | hr | 1311 | 2543 | 5013 | 0.5072 | 0.3326 |
MDA-MB-231 | PD0325901 | 0.12 | uM | LJP6 | 72 | hr | 1311 | 2371 | 5013 | 0.4729 | 0.2862 |
MDA-MB-231 | PD173074 | 0.12 | uM | LJP6 | 72 | hr | 1311 | 5103 | 5013 | 1.0178 | 1.0242 |
MDA-MB-231 | PD184352 | 0.12 | uM | LJP5 | 72 | hr | 1311 | 4341 | 5013 | 0.8660 | 0.8185 |
MDA-MB-231 | Pelitinib | 0.12 | uM | LJP5 | 72 | hr | 1311 | 5253 | 5013 | 1.0479 | 1.0649 |
MDA-MB-231 | PF431396 | 0.12 | uM | LJP5 | 72 | hr | 1311 | 4067 | 5013 | 0.8112 | 0.7443 |
MDA-MB-231 | PF477736 | 0.12 | uM | LJP5 | 72 | hr | 1311 | 5116 | 5013 | 1.0205 | 1.0278 |
MDA-MB-231 | PF562271 | 0.12 | uM | LJP6 | 72 | hr | 1311 | 4387 | 5013 | 0.8751 | 0.8308 |
MDA-MB-231 | PHA-665752 | 0.12 | uM | LJP5 | 72 | hr | 1311 | 4933 | 5013 | 0.9840 | 0.9783 |
MDA-MB-231 | PHA-793887 | 0.12 | uM | LJP6 | 72 | hr | 1311 | 2138 | 5013 | 0.4265 | 0.2233 |
MDA-MB-231 | PI103 | 0.12 | uM | LJP6 | 72 | hr | 1311 | 3706 | 5013 | 0.7393 | 0.6469 |
MDA-MB-231 | PLX-4720 | 0.12 | uM | LJP5 | 72 | hr | 1311 | 5140 | 5013 | 1.0252 | 1.0342 |
MDA-MB-231 | QL-X-138 | 0.12 | uM | LJP6 | 72 | hr | 1311 | 4378 | 5013 | 0.8732 | 0.8283 |
MDA-MB-231 | QL-XII-47 | 0.12 | uM | LJP6 | 72 | hr | 1311 | 3558 | 5013 | 0.7097 | 0.6068 |
MDA-MB-231 | Radicicol | 0.12 | uM | LJP5 | 72 | hr | 1311 | 4268 | 5013 | 0.8513 | 0.7986 |
MDA-MB-231 | Radicicol | 0.12 | uM | LJP6 | 72 | hr | 1311 | 4328 | 5013 | 0.8633 | 0.8148 |
MDA-MB-231 | Seliciclib | 0.12 | uM | LJP5 | 72 | hr | 1311 | 5018 | 5013 | 1.0009 | 1.0012 |
MDA-MB-231 | Ruxolitinib | 0.12 | uM | LJP5 | 72 | hr | 1311 | 4994 | 5013 | 0.9961 | 0.9947 |
MDA-MB-231 | XL147 | 0.12 | uM | LJP5 | 72 | hr | 1311 | 4825 | 5013 | 0.9625 | 0.9492 |
MDA-MB-231 | Saracatinib | 0.12 | uM | LJP6 | 72 | hr | 1311 | 3312 | 5013 | 0.6606 | 0.5404 |
MDA-MB-231 | Selumetinib | 0.12 | uM | LJP6 | 72 | hr | 1311 | 3266 | 5013 | 0.6514 | 0.5279 |
MDA-MB-231 | Sirolimus | 0.12 | uM | LJP6 | 72 | hr | 1311 | 4149 | 5013 | 0.8276 | 0.7666 |
MDA-MB-231 | Sorafenib | 0.12 | uM | LJP6 | 72 | hr | 1311 | 4641 | 5013 | 0.9258 | 0.8995 |
MDA-MB-231 | SU11274 | 0.12 | uM | LJP5 | 72 | hr | 1311 | 5214 | 5013 | 1.0401 | 1.0543 |
MDA-MB-231 | Fedratinib | 0.12 | uM | LJP5 | 72 | hr | 1311 | 4858 | 5013 | 0.9690 | 0.9580 |